Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo

about

Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo

Item

http://www.wikidata.org/entity/Q41285493

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo

@en

type

Item

label

Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo

@en

prefLabel

Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo

@en

P1476

Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo

@en

P2093

Dong Kyu Oh

http://www.w3.org/2001/XMLSchema#string

Hyeyoung Kim

http://www.w3.org/2001/XMLSchema#string

Hyo Sin Kim

http://www.w3.org/2001/XMLSchema#string

Kwang Woong Lee

http://www.w3.org/2001/XMLSchema#string

Kyung Chul Yoon

http://www.w3.org/2001/XMLSchema#string

Kyung Suk Suh

http://www.w3.org/2001/XMLSchema#string

Min Young Park

http://www.w3.org/2001/XMLSchema#string

Nadiar Mussin

http://www.w3.org/2001/XMLSchema#string

Nam Joon Yi

http://www.w3.org/2001/XMLSchema#string

Seung Cheol Oh

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence, risk factors and outcomes of de novo malignancies post liver transplantation

Burden of de novo malignancy in the liver transplant recipient

The LKB1-AMPK pathway: metabolism and growth control in tumour suppression

De novo malignancies following liver transplantation: a case-control study with long-term follow-up.

Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study

Post-transplant malignancy: the role of immunosuppression.

The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation.

mTOR inhibitors induce apoptosis in colon cancer cells via CHOP-dependent DR5 induction on 4E-BP1 dephosphorylation.

Incidence and risk factors for cancer after liver transplantation.

Metformin: From Research to Clinical Practice.

P304

1385-1395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3346/JKMS.2017.32.9.1385

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28776332

http://www.w3.org/2001/XMLSchema#string

P921

metformin

P932

5546956

http://www.w3.org/2001/XMLSchema#string